"Urging the United States Congress and the United States Food and Drug Administration to assist in the prompt approval of new drug applications for the treatment of prostate cancer. "
"This bill would urge Congress and the FDA to pursue prompt approval of new, targeted drug treatments for prostate cancer."
- Rep. Gatto
HJR 20 recognizes the great cost to the United States, and Alaska, that prostate cancer creates in terms of lives lost, decreased productivity, and insurance claims. This bill would urge Congress and the FDA to pursue prompt approval of new, targeted drug treatments for prostate cancer. No targeted drugs are currently approved for the treatment of prostate cancer. Prostate is the second leading cause of cancer related death in men. It is time we looked seriously at targeted drugs specifically for prostate cancer.
Five Alaskans a day are expected to die from cancer this year. We simply must find a way to lower this number through awareness, prevention, and effective treatment. This resolution serves each purpose by keeping the issue of prostate cancer in the forefront of Alaskans minds while seeking approval of drugs that may prove life saving for some and at least palliative for other, more dire, cases.
I urge your prompt and favorable action on this measure.